Christopher A. Viehbacher

Co-Founder at Gurnet Point Capital LLC

Christopher A. Viehbacher

Christopher A. Viehbacher

Co-Founder at Gurnet Point Capital LLC

Overview
Career Highlights

GlaxoSmithKline Plc
GlaxoSmithKline LLC
Latin American Pharmaceutical Operations

RelSci Relationships

4849

Primary Location

Raleigh, NC

Number of Boards

27

Birthday

03/1961

Age

59

Number of Awards

3

Contact Data
Trying to get in touch with Christopher A. Viehbacher? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Christopher A. Viehbacher likely has professional access to. A relationship does not necessarily indicate a personal connection.

General Partner at Hatteras Venture Partners

Relationship likelihood: Strong

Co-Founder at PureTech Health PLC

Relationship likelihood: Strong

Co-Founder at PureTech Health PLC

Relationship likelihood: Strong

Partner at Gurnet Point Capital LLC

Relationship likelihood: Strong

Co-Founder at Boston Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chair of Innovation at College de France

Relationship likelihood: Strong

Founder at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Senior Partner at Gurnet Point Capital LLC

Relationship likelihood: Strong

Managing Director at WestRiver Group

Relationship likelihood: Strong

Associate at Janssen Pharmaceuticals, Inc.

Relationship likelihood: Strong

Paths to Christopher A. Viehbacher
Potential Connections via
Relationship Science
You
Christopher A. Viehbacher
Co-Founder at Gurnet Point Capital LLC
Education
Graduate

Queen's University at Kingston (commonly shortened to Queen's University or Queen's) is a public research university located in Kingston, Ontario, Canada. Founded on 16 October 1841, the university predated the founding of Canada by 26 years. Queen's holds more than 1,400 hectares (3,500 acres) of land throughout Ontario and owns Herstmonceux Castle in East Sussex, England. Queen's is organized into ten undergraduate, graduate and professional faculties and schools. The Church of Scotland established Queen's College in 1841 with a royal charter from Queen Victoria. The first classes, intended to prepare students for the ministry, were held 7 March 1842 with 13 students and two professors. Queen's was the first university west of the maritime provinces to admit women, and to form a student government. In 1883, a women's college for medical education affiliated with Queen's University. In 1888, Queen's University began offering extension courses, becoming the first Canadian university to do so. In 1912, Queen's secularized and changed to its present legal name.

Memberships
Member
Prior

Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.

Career History
Co-Founder
2015 - Current

Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA.

Co-Founder
2015 - Current

Gurnet Point Capital invests in companies located in the US. The firm targets companies operating in the fields of life sciences and medical technologies. It provides financing for buyout and all stages of product development and acquires majority stake in the company.

Managing Partner
Current

Waypoint is the business enterprise for the managers and advisers associated with the Bertarelli family. Their history is that of a family of entrepreneurs and today that spirit lives on in a diversified range of business interests.

Boards & Committees
Member, Board of Directors
2008 - 2014

Sanofi, a diversified global healthcare leader, discovers, develops, and distributes therapeutic solutions to improve the lives of everyone. We work to prevent and treat the diseases that we know of today, as well as those we may face tomorrow. With nearly 100,000 dedicated professionals in more than 100 countries, Sanofi is devoted to advancing healthcare around the world. Sanofi US, with headquarters in Bridgewater, New Jersey, along with our vaccines division, Sanofi Pasteur, employs more than 11,400 professionals throughout the country. At Sanofi, we work for what really matters: health

Advisory Council Member
2008 - 2010
Member, Board of Directors
2004 - 2008
Trustee
Current

Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern is a leader in worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. Our broad mix of experience-based education programs—our signature cooperative education program, as well as student research, service learning, and global learning—build the connections that enable students to transform their lives. The University offers a comprehensive range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. Northeastern University's accreditation information

Chairman
2012 - Prior

The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association founded in 1978 representing the research-based pharmaceutical industry operating in Europe.

Director
2010 - 2012

Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$10K - $15K
2008

UNITED WAY OF THE GREATER TRIANGLE'S MISSION IS TO IMPROVE LIVES BY MOBILIZING THE CARING POWER OF COMMUNITIES.

$1,000 - $10K
2007

Research!America is the nation's largest not-for-profit public education and advocacy alliance working to make research to improve health a higher national priority. We urge Congress and the administration to increase funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Agency for Healthcare Research and Quality (AHRQ), Food and Drug Administration (FDA) and National Science Foundation (NSF) at levels that keep pace with scientific opportunity. We also advocate for federal funding for global health research and a legislative and regulatory climate that stimulates growth in industry research and development.

$10K - $15K
2007

UNITED WAY OF THE GREATER TRIANGLE'S MISSION IS TO IMPROVE LIVES BY MOBILIZING THE CARING POWER OF COMMUNITIES.

Political Donations
$2,600
2014

Representative from Michigan's 6th Congressional District

$2,600
2014

Former Representative from Oregon's 2nd Congressional District

$2,500
2013

Minority Leader from United States

Transactions
Details Hidden

Gurnet Point Capital LLC purchases Corium International, Inc.

Details Hidden

Gurnet Point Capital LLC purchases Innocoll Holdings Plc

Details Hidden

Sanofi purchases BiPar Sciences, Inc. from Canaan Management, Inc., Domain Associates LLC, Vulcan Ventures, Inc.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
2003
Knight of the French Legion of Honor
CPA (Certified Public Accountant)
CPA (Certified Public Accountant)
Events
Speaker
Switzerland
2013 World Economic Forum Annual Meeting

The World Economic Forum Annual Meeting 2013 continues the mission of the World Economic Forum. It is committed to improving the state of the world and has driven the design and development of the Annual Meeting programme. The Annual Meeting remains the foremost creative force for engaging leaders in collaborative activities focused on shaping the global, regional and industry agendas.

Attendee
Tianjin, GD, China
2012 World Economic Forum Annual Meeting of the New Champions

Speaker
Davos, Switzerland
2012 World Economic Forum Annual Meeting

A record 2,600 business, government and civil society leaders – including nearly 40 heads of state or government – participated in the 42nd World Economic Forum Annual Meeting, which took place under the theme The Great Transformation: Shaping New Models. The record participation indicated the international community’s level of concern for the world today, as one crisis after another emerges. It also underscored the commitment of the Forum’s Members, Partners and communities to improving the state of the world.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Christopher A. Viehbacher. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Christopher A. Viehbacher's profile does not indicate a business or promotional relationship of any kind between RelSci and Christopher A. Viehbacher.